Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
158.83
-1.02 (-0.64%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,626,409
Open
159.15
Bid (Size)
157.28 (200)
Ask (Size)
159.24 (100)
Prev. Close
159.85
Today's Range
157.32 - 159.37
52wk Range
112.34 - 170.46
Shares Outstanding
N/A
Dividend Yield
3.01%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Dividend Stocks to Buy for a Lifetime of Passive Income
↗
Today 13:20 EDT
These companies' recent headwinds shouldn't lead to decreased payouts.
Via
The Motley Fool
Topics
Intellectual Property
Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts
↗
Today 5:30 EDT
Via
Chartmill
Performance
YTD
+14.6%
+14.6%
1 Month
+0.8%
+0.8%
3 Month
+9.2%
+9.2%
6 Month
+4.3%
+4.3%
1 Year
+36.7%
+36.7%
More News
Read More
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
↗
July 23, 2026
Via
The Motley Fool
Topics
ETFs
Novartis (NVS) Q2 2026 Earnings Call Transcript
↗
July 21, 2026
Via
The Motley Fool
Topics
Earnings
NOVARTIS AG-SPONSORED ADR (NYSE:NVS): High-Quality Dividend Stock With Strong Profitability and Sustainable Payout
↗
July 07, 2026
Via
Chartmill
Novartis Q2 Earnings Call Highlights
↗
July 21, 2026
Via
MarketBeat
Topics
ETFs
Earnings
Novartis Q2 2026 Earnings Call Transcript
↗
July 21, 2026
Via
Benzinga
Topics
Earnings
Novartis Bounds For Buy Point. Why Shares Are On The Rise.
↗
July 21, 2026
Via
Investor's Business Daily
Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline
↗
July 21, 2026
Via
Benzinga
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
↗
July 20, 2026
Via
The Motley Fool
Topics
ETFs
This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval
↗
July 17, 2026
Via
Benzinga
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
July 14, 2026
Via
Newsfile
Global Nitrogen-Containing Bisphosphonate Drugs Market Growing at 3.1% CAGR Through 2032
↗
July 14, 2026
Via
Talk Markets
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
↗
July 09, 2026
Via
The Motley Fool
What Is the Vanguard International Dividend Appreciation ETF (VIGI), and Who Should Buy It?
↗
July 09, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
↗
July 09, 2026
Via
The Motley Fool
Topics
ETFs
VYMI vs. VIGI: Which International Dividend ETF Is Better?
↗
July 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
2 Fast-Growing Pharmaceutical Stocks to Buy Now
↗
July 08, 2026
Via
The Motley Fool
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
↗
July 08, 2026
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Stocks
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
July 06, 2026
Via
Investor Brand Network
Novartis Scoops up UK Biotech Myricx in $1.5 Billion Cancer Push
↗
July 06, 2026
Via
Benzinga
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
↗
July 04, 2026
Via
The Motley Fool
Topics
ETFs
New Research Says: The Biggest Gains of AI Won't Go to AI Stocks. These 2 ETFs Could Be Better Buys.
↗
July 04, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand.
↗
July 02, 2026
Via
The Motley Fool
Topics
ETFs
3 European Stocks to Carry Investors Through the Back Half of 2026
↗
July 01, 2026
Via
MarketBeat
Topics
ETFs
Stocks
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 158.83
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 07/29/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.